Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group

Brandao, Mariana; Prisciandaro, Elena; Xenophontos, Eleni; Mariolo, Alessio; Sadeghi, Amir H.; Filippi, Andrea R.; Levy, Antonin; Bandura, Artur; Caramella, Caroline; Dickhoff, Chris; de Margerie-Mellon, Constance; Faivre-Finn, Corinne; Portik, Daniel; Sanchez-Lorente, David; De Ruysscher, Dirk; Smit, Egbert; Gobbini, Elisa; Fadel, Elie; Ruffini, Enrico; Olmetto, Emanuela; Cortiula, Francesco; Bahce, Idris; Houda, Ilias; Opitz, Isabelle; Naidoo, Jarushka; Edwards, John; Remon, Jordi; Benitez, Jose Carlos; Trujillo, Juan Carlos; Derks, Jules; Amrane, Karim; Hartemink, Koen J.; Stathopoulos, Konstantinos; Hendriks, Lizza E. L.; Iglesias, Manoli; Occhipinti, Mario; Guckenberger, Matthias; Levra, Niccolo Giaj; Girard, Nicolas; Reguart, Noemi; Mercier, Olaf; Bironzo, Paolo; Hofman, Paul; Petersen, Rene Horsleben; De Angelis, Riccardo; Abgral, Ronan; Terrisse, Safae; Popat, Sanjay; Pierret, Thomas; Blum, Torsten Gerriet; Ricardi, Umberto; Dionisi, Valeria; Berghmans, Thierry; Dingemans, Anne-Marie C. – 2025 – 10.1016/j.lungcan.2025.108579